Startup Nome Partners with DAND Alliance to Develop Custom Treatments for Rare Genetic Disorder
Nome, a startup focused on developing custom treatments for rare diseases, is leveraging AI to streamline the process for families affected by genetic disorders. This innovation could significantly reduce costs and improve accessibility to personalized medicine, potentially transforming the landscape for rare disease treatment development.